Fujifilm Holdings Corp said it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States.
The trial will enrol about 50 COVID-19 patients in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital, and the University of Massachusetts Medical School, Fujifilm said on Thursday.
On March 31, Fujifilm announced the start of phase III clinical trial of Avigan for COVID-19 patients in Japan.
The International Court of Justice in The Hague said Friday it would issue a verdict…
Heavy rainfalls that hit Kenya during the last few days left at least 75 people…
International Olympic Committee (IOC) President Thomas Bach confirmed that the IOC is committed to inviting…
According to a bulletin from the National Institute of Meteorology (INM), the month of March…
Thousands of supporters of the Spanish Socialist Party assembled in Madrid, near the party headquarters,…
Journalist and human rights defender Kamel Sammari passed away today, Saturday, April 27. The deceased…
This website uses cookies.